Jamie N Connarn (Jamie Connarn)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Molecular Docking

Radical Prostatectomy

Top Venues

CPT: pharmacometrics & systems pharmacology

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Arya Pourzanjani, Saurabh Modi, Jamie N Connarn, Xinwen Zhang, Vijay V Upreti, Chih-Wei Lin, Khamir Mehta
A novel Bayesian generative approach for estimating tumor dynamics from published studies. CPT: pharmacometrics & systems pharmacology (2024)
Arya Pourzanjani, Saurabh Modi, Jamie N Connarn, Xinwen Zhang, Vijay V Upreti, Chih-Wei Lin, Khamir Mehta
A novel Bayesian generative approach for estimating tumor dynamics from published studies. CPT: pharmacometrics & systems pharmacology 13 (8) (2024)
Arya Pourzanjani, Saurabh Modi, Jamie N Connarn, Xinwen Zhang, Vijay V Upreti, Chih-Wei Lin, Khamir Mehta
A novel Bayesian generative approach for estimating tumor dynamics from published studies. CPT: pharmacometrics & systems pharmacology 13 (8) (2024)
Arya Pourzanjani, Saurabh Modi, Jamie N Connarn, Xinwen Zhang, Vijay V Upreti, Chih-Wei Lin, Khamir Mehta
A novel Bayesian generative approach for estimating tumor dynamics from published studies. CPT: pharmacometrics & systems pharmacology 13 (8) (2024)
William Kevin Kelly, Daniel Costin Danila, Chia-Chi Lin, Jae Lyun Lee, Nobuaki Matsubara, Patrick J Ward, Andrew J Armstrong, David W Pook, Miso Kim, Tanya Barauskas Dorff, Stefanie Fischer, Yung-Chang Lin, Lisa G Horvath, Christopher Sumey, Zhao Yang, Gabor Jurida, Kristen M Smith, Jamie N Connarn, Hweixian Leong Penny, Julia Stieglmaier, Leonard J Appleman
Xaluritamig, a STEAP1 × CD3 XmAb 2+1 Immune Therapy for Metastatic Castration-Resistant Prostate Cancer: Results from Dose Exploration in a First-in-Human Study. Cancer discovery (2023)